StockClub

CARM

CARMCarisma Therapeutics, Inc.$ --
Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.

CARM

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
45M USD
YoY +1236.8%
Operating Income
44M USD
YoY +433.3%
Net Income
45M USD
YoY +452.0%
EPS
1.07$
YoY +445.2%

Revenue

$49M
FY2023 Q4$14.9M
$14.9M
Q4
FY2024 Q1$3.4M
$3.4M
Q1
FY2024 Q2$12.6M
$12.6M
Q2
FY2024 Q3$16M
$16M
Q3
FY2024 Q4$19.6M
$19.6M
Q4
FY2025 Q1$3.7M
$3.7M
Q1
FY2025 Q2$3.7M
$3.7M
Q2
FY2025 Q3$49M
$49M
Q3
Actual
+$33M (+206.5%)

Net Income

$25.7M
FY2023 Q4$-86.9M
$-86.9M
Q4
FY2024 Q1$-19M
$-19M
Q1
FY2024 Q2$-30.1M
$-30.1M
Q2
FY2024 Q3$-42.8M
$-42.8M
Q3
FY2024 Q4$-60.5M
$-60.5M
Q4
FY2025 Q1$-9.3M
$-9.3M
Q1
FY2025 Q2$-19M
$-19M
Q2
FY2025 Q3$25.7M
$25.7M
Q3
Actual
+$68.5M (+159.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$0
FY2019
$0
FY2020BEAT
Actual:$11.2M
Est:$11.2M
FY2020BEAT
$11.2M
FY2021BEAT
Actual:$26.5M
Est:$6.5M
FY2021BEAT
$26.5M
FY2022MISS
Actual:$9.8M
Est:$40M
FY2022MISS
$9.8M
FY2023MISS
Actual:$14.9M
Est:$15.1M
FY2023MISS
$14.9M
FY2024MISS
Actual:$19.6M
Est:$21.1M
FY2024MISS
$19.6M

Analyst Estimates